GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Ltd (BOM:500680) » Definitions » YoY EBITDA Growth

Pfizer (BOM:500680) YoY EBITDA Growth : 68.25% (As of Mar. 2025)


View and export this data going back to 1991. Start your Free Trial

What is Pfizer YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Pfizer's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 68.25%.

Pfizer's EBITDA per Share for the three months ended in Mar. 2025 was ₹97.28.


Pfizer YoY EBITDA Growth Historical Data

The historical data trend for Pfizer's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer YoY EBITDA Growth Chart

Pfizer Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.85 13.25 4.96 -12.64 31.75

Pfizer Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.59 52.15 6.23 -3.90 68.25

Pfizer YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Pfizer's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (A: Mar. 2025 )
=(EBITDA per Share (A: Mar. 2025 )-EBITDA per Share (A: Mar. 2024 ))/ | EBITDA per Share (A: Mar. 2024 ) |
=(237.232-180.057)/ | 180.057 |
=31.75 %

Pfizer's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(97.278-57.816)/ | 57.816 |
=68.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pfizer YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Pfizer's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer Business Description

Traded in Other Exchanges
Address
The Capital, 1802/1901, 18th Floor, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company has only one segment which is Pharmaceuticals and it operates in domestic market.

Pfizer Headlines

No Headlines